A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.

MLA

Masters, G. A., et al. “A Phase I-II Study of Paclitaxel, Ifosfamide, and Vinorelbine with Filgrastim (RhG-CSF) Support in Advanced Non-Small-Cell Lung Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 9, no. 6, June 1998, pp. 677–80. EBSCOhost, https://doi.org/10.1023/a:1008217613774.

APA

Masters, G. A., Mauer, A. M., Hoffman, P. C., Wyka, D., Samuels, B. L., Krauss, S. A., Watson, S., Golomb, H., & Vokes, E. E. (1998). A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 9(6), 677–680. https://doi.org/10.1023/a:1008217613774

Chicago

Masters, G A, A M Mauer, P C Hoffman, D Wyka, B L Samuels, S A Krauss, S Watson, H Golomb, and E E Vokes. 1998. “A Phase I-II Study of Paclitaxel, Ifosfamide, and Vinorelbine with Filgrastim (RhG-CSF) Support in Advanced Non-Small-Cell Lung Cancer.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 9 (6): 677–80. doi:10.1023/a:1008217613774.